EDGAR Filing Documents for 0001193125-08-057666

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-08-057666

Filing Date

2008-03-17

Accepted

2008-03-14 18:28:54

Documents

Period of Report

2007-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1128280
2	FORM OF 2007 RESTRICTED STOCK AWARD AGREEMENT	dex1015.htm	EX-10.1.5	19702
3	FORM OF INDEMNIFICATION AGREEMENT	dex104.htm	EX-10.4	3323
4	SIXTH AMENDMENT TO LEASE AGREEMENT	dex1096.htm	EX-10.9.6	32449
5	CONSENT TO ASSIGNMENT OF LEASE AGREEMENT	dex1010.htm	EX-10.10	18851
6	FIRST AMENDMENT TO CONSENT OF SUBLEASE AGREEMENT	dex1011.htm	EX-10.11	239183
7	SIDE LETTER	dex1014.htm	EX-10.14	5374
8	ANTIGENICS CONSENT AGREEMENT	dex10151.htm	EX-10.15	15696
9	AMENDMENT NO. 1,2,3,5,6 AND 7 TO EXCLUSIVE LICENSE AGREEMENT WITH ARONEX PHARM.	dex10181.htm	EX-10.18.1	505041
10	AMENDED & RESTATED LICENSE AGREEMENT	dex1019.htm	EX-10.19	36866
11	2004 EXECUTIVE INCENTIVE PLAN	dex1028.htm	EX-10.28	10977
12	CONSENT OF KPMG LLP	dex23.htm	EX-23	2293
13	CERTIFICATION OF CEO PURSUANT TO SECTION 302	dex311.htm	EX-31.1	9699
14	CERTIFICATION OF CFO PURSUANT TO SECTION 302	dex312.htm	EX-31.2	9673
15	CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906	dex321.htm	EX-32.1	4493
16	GRAPHIC	g38122g33s77.jpg	GRAPHIC	50088
17	GRAPHIC	g38122img001.jpg	GRAPHIC	10174
	Complete submission text file	0001193125-08-057666.txt		2126642

Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111

Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200

ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)